药研通(参比购)-免费查询参比制剂目录,一站式代理进口全球参比制剂。
仿制药参比制剂目录(第二十二批)
序号 |
药品通用名称 | 英文名称/商品名 | 规格 | 剂型 | 持证商 | 备注1 | 备注2 | |
|---|---|---|---|---|---|---|---|---|
22-1 |
丙氨酰谷氨酰胺注射液 |
Alanyl Glutamine Injection/ Dipeptiven(力太) |
50ml:10g |
注射剂 |
Fresenius Kabi Austria GmbH |
国内上市的原研药品 |
||
22-2 |
丙氨酰谷氨酰胺注射液 |
Alanyl Glutamine Injection/ Dipeptiven(力太) |
100ml:20g |
注射剂 |
Fresenius Kabi Austria GmbH |
国内上市的原研药品 |
||
22-3 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection /ALFENTA |
2ml:1mg(以阿芬太尼计) |
注射剂 |
AKORN INC |
未进口原研药品 |
||
22-4 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection /RAPIFEN |
2ml:1mg(以阿芬太尼计) |
注射剂 |
Piramal Critical Care Ltd |
未进口原研药品 |
||
22-5 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection /ALFENTA |
5ml:2.5mg(以阿芬太尼计) |
注射剂 |
AKORN INC/AKORN OPERATING CO LLC |
未进口原研药品 |
||
22-6 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection /ALFENTA |
10ml:5mg(以阿芬太尼计) |
注射剂 |
AKORN INC |
未进口原研药品 |
||
22-7 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection /RAPIFEN |
10ml:5mg(以阿芬太尼计) |
注射剂 |
Piramal Critical Care Ltd |
未进口原研药品 |
||
22-8 |
盐酸阿芬太尼注射液 |
Alfentanil Hydrochloride Injection/Rapifen Intensive Care |
1ml:5mg(以阿芬太尼计) |
注射剂 |
Piramal Critical Care Ltd |
未进口原研药品 |
||
22-9 |
阿齐沙坦片 |
Azilsartan Tablets /AZILVA |
20mg |
片剂 |
Takeda Pharmaceutical Co., Ltd. |
未进口原研药品 |
||
22-10 |
阿齐沙坦片 |
Azilsartan Tablets /AZILVA |
40mg |
片剂 |
Takeda Pharmaceutical Co., Ltd. |
未进口原研药品 |
||
22-11 |
氨氯地平阿托伐他汀钙片 |
Amlodipine Besylate and Atorvastatin Calcium Tablets /CADUET |
氨氯地平10mg,阿托伐他汀10mg |
片剂 |
PFIZER INC |
未进口原研药品 |
||
22-12 |
奥氮平盐酸氟西汀胶囊 |
Olanzapine and Fluoxetine HydrochlorideCapsules/SYMBYAX |
奥氮平3mg,氟西汀25mg |
胶囊剂 |
ELI LILLY AND CO |
未进口原研药品 |
||
22-13 |
奥氮平盐酸氟西汀胶囊 |
Olanzapine and Fluoxetine HydrochlorideCapsules/SYMBYAX |
奥氮平6mg,氟西汀25mg |
胶囊剂 |
ELI LILLY AND CO |
未进口原研药品 |
||
22-14 |
奥氮平盐酸氟西汀胶囊 |
Olanzapine and Fluoxetine HydrochlorideCapsules/SYMBYAX |
奥氮平12mg,氟西汀25mg |
胶囊剂 |
ELI LILLY AND CO |
未进口原研药品 |
||
22-15 |
奥氮平盐酸氟西汀胶囊 |
Olanzapine and Fluoxetine HydrochlorideCapsules/SYMBYAX |
奥氮平6mg,氟西汀50mg |
胶囊剂 |
ELI LILLY AND CO |
未进口原研药品 |
||
22-16 |
奥氮平盐酸氟西汀胶囊 |
Olanzapine and Fluoxetine HydrochlorideCapsules/SYMBYAX |
奥氮平12mg,氟西汀50mg |
胶囊剂 |
ELI LILLY AND CO |
未进口原研药品 |
||
22-17 |
白消安注射液 |
Busulfan Injection/BUSULFEX(白舒非) |
10ml:60mg |
注射剂 |
Otsuka Pharmaceutical Co., Ltd. |
国内上市的原研药品 |
||
22-18 |
复方氨基酸(15)双肽(2)注射液 |
Compound Amino Acids (15) and Dipeptides (2) Injection/Glavamin |
250ml:33.5g |
注射剂 |
Fresenius Kabi Deutschland GmbH |
未进口原研药品 |
||
22-19 |
复方氨基酸(15)双肽(2)注射液 |
Compound Amino Acids (15) and Dipeptides (2) Injection/Glamin(谷安光) |
500ml:67g |
注射剂 |
Fresenius Kabi Austria GmbH |
国内上市的原研药品 |
||
22-20 |
复方氨基酸(15)双肽(2)注射液 |
Compound Amino Acids (15) and Dipeptides (2) Injection/Glamin(谷安光) |
1000ml:134g |
注射剂 |
Fresenius Kabi Austria GmbH |
国内上市的原研药品 |
||
22-21 |
脂肪乳氨基酸(17)葡萄糖(11%)注射液 |
Fat Emulsion,Amino Acids(17) and Glucose(11%) Injection/Kabiven PI(卡文) |
1440ml |
注射剂 |
Fresenius Kabi AB |
国内上市的原研药品 |
||
22-22 |
脂肪乳氨基酸(17)葡萄糖(11%)注射液 |
Fat Emulsion,Amino Acids(17) and Glucose(11%) Injection/Kabiven PI(卡文) |
1920ml |
注射剂 |
Fresenius Kabi AB |
国内上市的原研药品 |
||
22-23 |
脂肪乳氨基酸(17)葡萄糖(11%)注射液 |
Fat Emulsion,Amino Acids(17) and Glucose(11%) Injection/Kabiven PI(卡文) |
2400ml |
注射剂 |
Fresenius Kabi AB |
国内上市的原研药品 |
||
22-24 |
复方氨基酸注射液(20AA) |
Compound Amino Acid Injection/Aminoplasmal Hepa-10%(安平) |
500ml:50g |
注射剂 |
B.Braun Melsungen AG |
国内上市的原研药品 |
||
22-25 |
复方氨基酸注射液(20AA) |
Compound Amino Acid Injection/Aminoplasmal Hepa-10% |
1000ml:100g |
注射剂 |
B.Braun Melsungen AG |
未进口原研药品 |
||
22-26 |
醋酸艾替班特注射液 |
Icatibant Acetate Solution for Injection in Pre-filled Syringe/Firazyr |
3ml:30mg预灌封注射器 |
注射剂 |
Shire Pharmaceuticals Ireland Limited |
未进口原研药品 |
||
22-27 |
苯丁酸钠散/颗粒 |
Sodium Phenylbutyrate Powder/BUPHENYL |
3GM/TEASPOONFUL(940mg/g) |
散剂/颗粒剂 |
Horizon Therapeutics, LLC |
未进口原研药品 |
||
22-28 |
苯丁酸钠片 |
Sodium Phenylbutyrate Tablets/BUPHENYL |
500mg |
片剂 |
Horizon Therapeutics, LLC |
未进口原研药品 |
||
22-29 |
阿立哌唑口崩片 |
Aripiprazole Orodispersible Tablets/ABILIFY |
15mg |
片剂 |
Otsuka Pharmaceutical Netherlands B.V. |
未进口原研药品 |
||
22-30 |
阿立哌唑口崩片 |
Aripiprazole Orodispersible Tablets/ABILIFY |
30mg |
片剂 |
Otsuka Pharmaceutical Netherlands B.V. |
未进口原研药品 |
||
22-31 |
阿立哌唑口服溶液 |
Aripiprazole Oral Solution/ABILIFY |
1mg/ml(50ml:50mg) |
口服溶液剂 |
Otsuka Pharmaceutical Netherlands B.V. |
未进口原研药品 |
||
22-32 |
阿立哌唑口服溶液 |
Aripiprazole Oral Solution/ABILIFY |
1mg/ml(150ml:150mg) |
口服溶液剂 |
Otsuka Pharmaceutical Netherlands B.V. |
未进口原研药品 |
||
22-33 |
阿立哌唑口服溶液 |
Aripiprazole Oral Solution/ABILIFY |
1mg/ml(480ml:480mg) |
口服溶液剂 |
Otsuka Pharmaceutical Netherlands B.V. |
未进口原研药品 |
||
22-34 |
阿立哌唑长效肌肉注射剂/注射用阿立哌唑 |
Aripiprazole Powder and Solvent for Prolonged-release Suspension for Injection/Abilify Maintena |
300mg |
注射剂 |
Otsuka Pharmaceutical Co., Ltd. |
未进口原研药品 |
||
22-35 |
阿立哌唑长效肌肉注射剂/注射用阿立哌唑 |
Aripiprazole Powder and Solvent for Prolonged-release Suspension for Injection/Abilify Maintena |
400mg |
注射剂 |
Otsuka Pharmaceutical Co., Ltd. |
未进口原研药品 |
||
22-36 |
盐酸阿那格雷胶囊 |
Anagrelide Hydrochloride Capsules/AGRYLIN |
EQ 0.5MG BASE |
胶囊剂 |
Shire Development LLC/Takeda Pharmaceuticals Usa Inc |
未进口原研药品 |
||
22-37 |
奥美沙坦酯氢氯噻嗪片 |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL/BENICAR HCT |
40mg/12.5mg |
片剂 |
DAIICHI SANKYO INC |
未进口原研药品 |
||
22-38 |
奥美沙坦酯氢氯噻嗪片 |
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL/BENICAR HCT |
40mg/25mg |
片剂 |
DAIICHI SANKYO INC |
未进口原研药品 |
||
22-39 |
丙戊酸钠口服溶液 |
Sodium Valproate Liquid/DEPAKINE |
200mg/mL |
口服溶液剂 |
Sanofi aventis France |
未进口原研药品 |
||
22-40 |
丙戊酸钠注射用浓溶液 |
Sodium Valproate Concentrated Solution for Injection /Depacon |
5ml:500mg |
注射液 |
ABBVIE INC |
未进口原研药品 |
||
22-41 |
硫酸阿托品滴眼液 |
Atropine Sulfate Ophthalmic Solution, USP 1% |
1%(2ML) |
滴眼液 |
AKORN INC |
未进口原研药品 |
||
22-42 |
硫酸阿托品滴眼液 |
Atropine Sulfate Ophthalmic Solution, USP 1% |
1%(5ML) |
滴眼液 |
AKORN INC |
未进口原研药品 |
||
22-43 |
硫酸阿托品滴眼液 |
Atropine Sulfate Ophthalmic Solution, USP 1% |
1%(15ML) |
滴眼液 |
AKORN INC |
未进口原研药品 |
||
22-44 |
盐酸氨溴索口腔喷雾溶液 |
Ambroxol Hydrochloride Oral Spray /AMBROSPRAY 5% |
5%(50MG/G)SPR 13ML,10mg/喷;5%(50MG/G)SPR 25ML,10mg/喷; |
口腔喷雾溶液剂 |
CYATHUS Exquirere PharmaforschungsGmbH |
未进口原研药品 |
||
22-45 |
苯甲酸阿格列汀片 |
ALOGLIPTINBENZOATE ORAL TABLET/NESINA |
EQ6.25MGBASE |
片剂 |
TAKEDA PHARMACEUTICALS USA INC |
未进口原研药品 |
||
22-46 |
苯甲酸阿格列汀片 |
ALOGLIPTINBENZOATE TABLETs/NESINA(尼欣那) |
按C18H21N5O2计,12.5mg |
片剂 |
Takeda Pharmaceutical Company Limited/TEIJIN PHARMA LIMITED |
国内上市的原研药品 |
||
22-47 |
苯甲酸阿格列汀片 |
ALOGLIPTINBENZOATE TABLETs/NESINA(尼欣那) |
按C18H21N5O2计,25mg |
片剂 |
Takeda Pharmaceutical Company Limited/TEIJIN PHARMA LIMITED |
国内上市的原研药品 |
||
22-48 |
盐酸表柔比星注射液 |
Epirubicin Hydrochloride Injection/FARMORUBICINE |
10mg/5ml |
注射剂 |
PFIZER HOLDING FRANCE (S.C.A.) |
未进口原研药品 |
||
22-49 |
盐酸表柔比星注射液 |
Epirubicin Hydrochloride Injection/FARMORUBICINE |
20mg/10ml |
注射剂 |
PFIZER HOLDING FRANCE (S.C.A.) |
未进口原研药品 |
||
22-50 |
盐酸表柔比星注射液 |
Epirubicin Hydrochloride Injection/FARMORUBICINE |
50mg/25ml |
注射剂 |
PFIZER HOLDING FRANCE (S.C.A.) |
未进口原研药品 |
||
22-51 |
盐酸表柔比星注射液 |
Epirubicin hydrochloride injection/ELLENCE |
50MG/25ML(2MG/ML) |
注射剂 |
PFIZER INC |
未进口原研药品 |
||
22-52 |
盐酸表柔比星注射液 |
Epirubicin Hydrochloride Injection/FARMORUBICINE |
200mg/100ml |
注射剂 |
PFIZER HOLDING FRANCE (S.C.A.) |
未进口原研药品 |
||
22-53 |
盐酸表柔比星注射液 |
Epirubicin hydrochloride injection/ELLENCE |
200MG/100ML(2MG/ML) |
注射剂 |
PFIZER INC |
未进口原研药品 |
||
22-54 |
达比加群酯胶囊 |
Dabigatran etexilate mesylate capsules /PRADAXA |
EQ 75MG BASE |
胶囊剂 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
未进口原研药品 |
||
22-55 |
达比加群酯胶囊 |
Dabigatran Etexilate Capsules /Pradaxa |
75mg |
胶囊剂 |
Boehringer Ingelheim International GmbH |
未进口原研药品 |
||
22-56 |
阿普唑仑缓释片 |
Alprazolam extended-release tablets/XANAX XR™ |
0.5MG |
片剂(缓释片) |
Pharmacia & Upjohn |
未进口原研药品 |
||
22-57 |
阿普唑仑缓释片 |
Alprazolam extended-release tablets/XANAX XR™ |
1MG |
片剂(缓释片) |
Pharmacia & Upjohn |
未进口原研药品 |
||
22-58 |
阿普唑仑缓释片 |
Alprazolam extended-release tablets/XANAX XR™ |
2MG |
片剂(缓释片) |
Pharmacia & Upjohn |
未进口原研药品 |
||
22-59 |
阿普唑仑缓释片 |
Alprazolam extended-release tablets/XANAX XR™ |
3MG |
片剂(缓释片) |
Pharmacia & Upjohn |
未进口原研药品 |
||
22-60 |
醋酸艾司利卡西平片 |
Eslicarbazepine acetate tablets/APTIOM |
200MG |
片剂 |
SUNOVION PHARMACEUTICALS INC/SUMITOMO PHARMA AMERICA INC |
未进口原研药品 |
||
22-61 |
醋酸艾司利卡西平片 |
Eslicarbazepine acetate tablets/APTIOM |
400MG |
片剂 |
SUNSUNOVION PHARMACEUTICALS INC/SUMITOMO PHARMA AMERICA INC |
未进口原研药品 |
||
22-62 |
醋酸艾司利卡西平片 |
Eslicarbazepine acetate tablets/APTIOM |
600MG |
片剂 |
SUNOVION PHARMACEUTICALS INC/SUMITOMO PHARMA AMERICA INC |
未进口原研药品 |
||
22-63 |
醋酸艾司利卡西平片 |
Eslicarbazepine acetate tablets/APTIOM |
800MG |
片剂 |
SUNOVION PHARMACEUTICALS INC/SUMITOMO PHARMA AMERICA INC |
未进口原研药品 |
||
22-64 |
泊马度胺胶囊 |
Pomalidomide capsules/Pomalyst |
1mg |
胶囊 |
CELGENE |
未进口原研药品 |
||
22-65 |
泊马度胺胶囊 |
Pomalidomide capsules/ Imnovid |
1mg |
胶囊 |
Celgene Europe Ltd./Celgene Europe B.V. |
未进口原研药品 |
||
22-66 |
泊马度胺胶囊 |
Pomalidomide capsules/Pomalyst |
2mg |
胶囊 |
CELGENE |
未进口原研药品 |
||
22-67 |
泊马度胺胶囊 |
Pomalidomide capsules/Imnovid |
2mg |
胶囊 |
Celgene Europe Ltd./Celgene Europe B.V. |
未进口原研药品 |
||
22-68 |
泊马度胺胶囊 |
Pomalidomide capsules/Pomalyst |
3mg |
胶囊 |
CELGENE |
未进口原研药品 |
||
22-69 |
泊马度胺胶囊 |
Pomalidomide capsules/Imnovid |
3mg |
胶囊 |
Celgene Europe Ltd./Celgene Europe B.V. |
未进口原研药品 |
||
22-70 |
泊马度胺胶囊 |
Pomalidomide capsules/Pomalyst |
4mg |
胶囊 |
CELGENE |
未进口原研药品 |
||
22-71 |
泊马度胺胶囊 |
Pomalidomide capsules/ Imnovid |
4mg |
胶囊 |
Celgene Europe Ltd./Celgene Europe B.V. |
未进口原研药品 |
||
22-72 |
泊沙康唑注射液 |
Posaconazole Injection/NOXAFIL |
300MG/16.7ML(18MG/ML) |
注射液 |
MERCK SHARP DOHME |
未进口原研药品 |
||
22-73 |
泊沙康唑肠溶片 |
Posaconazole Enteric-coated Tablets/NOXAFIL |
100mg |
片剂 |
Merck Sharp & Dohme Ltd/Merck Sharp & Dohme B.V |
国内上市的原研药品 |
||
22-74 |
泊沙康唑肠溶片 |
Posaconazole Enteric-coated Tablets NOXAFIL |
100mg |
片剂 |
Merck Sharp & Dohme Ltd/Merck Sharp & Dohme Corp. |
未进口原研药品 |
||
22-75 |
苯甲酸利扎曲普坦片 |
Rizatriptan Monobenzoate Tablets/Maxalt |
5mg |
片剂 |
Merck Sharp & Dohme Limited/Organon Pharma (UK) Limited/Organon Healthcare GmbH |
未进口原研药品 |
||
22-76 |
苯甲酸利扎曲普坦片 |
Rizatriptan Monobenzoate Tablets/Maxalt |
10mg |
片剂 |
Merck & Co., Inc./Organon LLC |
未进口原研药品 |
||
22-77 |
苯甲酸利扎曲普坦口腔崩解片 |
Rizatriptan Monobenzoate Oral Disintegrating Tablets/Maxalt-MLT |
10mg |
片剂 |
Merck & Co., Inc./ Organon LLC A Sub Of Organon And Co |
未进口原研药品 |
||
22-78 |
阿哌沙班片 |
Apixaban Tablets/Eliquis |
5mg |
片剂 |
BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE |
未进口原研药品 |
||
22-79 |
双氯芬酸钠双释放肠溶胶囊 |
Diclofenac Sodium Dual Release Enteric-coated Capsules/Difene(戴芬) |
75mg |
胶囊剂 |
Temmler Werke GmbH /Aenova IP GmbH |
国内上市的原研药品 |
||
22-80 |
利格列汀二甲双胍片 |
Linagliptin and Metformin Hydrochloride Tablets/ Trajenta Duo(欧双宁) |
每片含利格列汀2.5 mg与盐酸二甲双胍500 mg |
片剂 |
Boehringer Ingelheim (Schweiz) GmbH |
国内上市的原研药品 |
||
22-81 |
利格列汀二甲双胍片 |
Linagliptin and Metformin Hydrochloride Tablets/ Trajenta Duo(欧双宁) |
每片含利格列汀2.5 mg与盐酸二甲双胍850 mg |
片剂 |
Boehringer Ingelheim (Schweiz)GmbH/ Boehringer Ingelheim International GmbH |
国内上市的原研药品 |
||
22-82 |
利格列汀二甲双胍片 |
Linagliptin and Metformin hydrochloride tablets/Jentadueto |
每片含利格列汀2.5 mg与盐酸二甲双胍1000mg mg |
片剂 |
Boehringer Ingelheim (Schweiz)gmbH/Boehringer Ingelheim Pharmaceuticals Inc |
未进口原研药品 |
||
22-83 |
苯丁酸氮芥片 |
Chlorambucil Tablets/Leukeran(留可然) |
2mg |
片剂 |
Aspen Pharmacare Australia Pty Ltd |
国内上市的原研药品 |
||
22-84 |
盐酸甲哌卡因注射液 |
Mepivacaine Hydrochloride Injection /Carbocain |
1%(30mL) |
注射剂 |
Hospira Inc. |
未进口原研药品 |
||
22-85 |
盐酸甲哌卡因注射液 |
Mepivacaine Hydrochloride Injection /Carbocain |
1%(50mL) |
注射剂 |
Hospira Inc. |
未进口原研药品 |
||
22-86 |
盐酸甲哌卡因注射液 |
Mepivacaine Hydrochloride Injection /Carbocain |
1.5%(30mL) |
注射剂 |
Hospira Inc. |
未进口原研药品 |
||
22-87 |
盐酸甲哌卡因注射液 |
Mepivacaine Hydrochloride Injection /Carbocain |
2%(20mL) |
注射剂 |
Hospira Inc. |
未进口原研药品 |
||
22-88 |
盐酸甲哌卡因注射液 |
Mepivacaine Hydrochloride Injection /Carbocain |
2%(50mL) |
注射剂 |
Hospira Inc. |
未进口原研药品 |
||
22-89 |
注射用奥美拉唑钠 |
Omeprazole Sodium for Injection/洛赛克 |
40mg(以奥美拉唑计) |
注射剂 |
阿斯利康制药有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
||
22-90 |
注射用奥美拉唑钠(静脉滴注) |
Omeprazole Sodium for Injection(Intravenous Infusion)/洛赛克 |
40mg(以奥美拉唑计) |
注射剂 |
阿斯利康制药有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
||
22-91 |
注射用艾司奥美拉唑钠 |
Esomeprazole Sodium For Injection |
40mg (按C17H19N3O3S计) |
注射剂 |
阿斯利康制药有限公司 |
经审核确定的国外原研企业在中国境内生产的药品 |
||
22-92 |
地塞米松棕榈酸酯注射液 |
Dexamethasone Palmitate Injection/多力生 |
1ml:4mg(以地塞米松棕榈酸酯计) |
注射剂 |
Mitsubishi Tanabe Pharma Corporation |
国内上市的原研药品 |
||
22-93 |
卡谷氨酸片 |
Carglumic Acid Dispersible Tablets/Carbaglu |
200mg |
片剂 |
Orphan Europe SARL |
未进口原研药品 |
||
22-94 |
卡谷氨酸片 |
Carglumic Acid Tablet For Oral Suspension/CARBAGLU |
200MG |
片剂 |
ORPHAN EUROPE |
未进口原研药品 |
||
22-95 |
唑来膦酸注射液 |
Zoledronic Acid Injection/ZOMETA |
EQ 4MG BASE/100ML |
注射剂 |
NOVARTIS PHARMACEUTICALS CORP |
未进口原研药品 |
||
22-96 |
唑来膦酸注射液 |
Zoledronic Acid Injection/Zometa |
4mg:100ml |
注射剂 |
Novartis Europharm Limited/Phoenix Labs Unlimited Company |
未进口原研药品 |
||
22-97 |
唑来膦酸注射液 |
Zoledronic Acid Injection/ゾメタ(ZOMETA) |
4mg/100mL |
注射剂 |
ノバルティスファーマ株式会社 |
未进口原研药品 |
||
22-98 |
恩格列净片 |
Empagliflozin Tablets /Jardiance(欧唐静) |
10mg |
片剂 |
Boehringer Ingelheim International GmbH |
国内上市的原研药品 |
||
22-99 |
恩格列净片 |
Empagliflozin Tablets /Jardiance(欧唐静) |
25mg |
片剂 |
Boehringer Ingelheim International GmbH |
国内上市的原研药品 |
||
22-100 |
二甲双胍维格列汀片(II) |
Metformin Hydrochloride and VildagliptinTablets (II)/Eucreas(宜合瑞) |
每片含盐酸二甲双胍850mg和维格列汀50mg |
片剂 |
Novartis Pharma Schweiz AG |
国内上市的原研药品 |
1.网站数据库说明:本网站所有仿制药参比制剂目录数据源自国家药品监督管理局官方网站;
2.参比制剂选择原则:有原研进口的应选择原研进口药作为参比制剂首选;


